e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid
Betsuyaku T., Kuroki Y., Nagai K., Nasuhara Y., Nishimura M.
Source:
Eur Respir J 2004; 24: 964-970
Journal Issue:
December
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Betsuyaku T., Kuroki Y., Nagai K., Nasuhara Y., Nishimura M.. Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid. Eur Respir J 2004; 24: 964-970
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema
Source: Eur Respir J 2005; 25: 275-281
Year: 2005
Sampling the lung fluids: peripheral biomarkers
Source: Annual Congress 2007 - Pulmonary biomarkers in COPD
Year: 2007
Surfactant protein D and its oligomeric forms in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010
Early detection of lung disease in cystic fibrosis
Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage
Year: 2007
Is there any correlation between apoptosis of the cells from bronchoalveolar lavage fluid (BALF) and the progression of chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Calgranuline B in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Th1/Th2/Th17-related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis in relation to smoking
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
Influence of smoking on bronchoalveolar lavage cellular pattern in sarcoidosis
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
Long term follow up of the whole lung lavage programme in patients with pulmonary alveolar proteinosis: an update
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Effects of N-acetylcystein on oxidant-antioxidant activity in smokers with chronic obstructive pulmonary disease
Source: Annual Congress 2005 - What's new in tobacco and lung disease
Year: 2005
Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 67s
Year: 2001
Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003
The decrease of surfactant protein D in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Relationship between Ca19.9 levels in bronchoalveolar lavage, neutrophilic alveolitis, pulmonary function tests and HRCT pattern in pulmonary fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 588s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept